NO20045659L - Forbindelser - Google Patents

Forbindelser

Info

Publication number: NO20045659L
Authority: NO; Norway
Prior art keywords: compounds
Prior art date: 2002-05-29

Application number

NO20045659A

Other languages

English (en)

Other versions

NO330118B1 (no

Inventor

Andrew Derrick Gribble

Andrew Hele Payne

Graham Walker

Andrew P Lightfoot

Ian Thomson Forbes

Vincenzo Garzya

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-05-29

Filing date

2004-12-27

Publication date

2004-12-27

2002-05-29 Priority claimed from GB0212401A external-priority patent/GB0212401D0/en

2002-12-23 Priority claimed from GB0230053A external-priority patent/GB0230053D0/en

2004-12-27 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2004-12-27 Publication of NO20045659L publication Critical patent/NO20045659L/no

2011-02-21 Publication of NO330118B1 publication Critical patent/NO330118B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Addiction (AREA)
Reproductive Health (AREA)
Pain & Pain Management (AREA)
Obesity (AREA)
Psychology (AREA)
Endocrinology (AREA)
Hematology (AREA)
Diabetes (AREA)
Hospice & Palliative Care (AREA)
Gynecology & Obstetrics (AREA)
Cardiology (AREA)
Child & Adolescent Psychology (AREA)
Anesthesiology (AREA)
Heart & Thoracic Surgery (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Other In-Based Heterocyclic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Indole Compounds (AREA)
Hydrogenated Pyridines (AREA)

NO20045659A 2002-05-29 2004-12-27 Nye forbindelser, farmasoytisk sammensetning, anvendelse NO330118B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB0212401A GB0212401D0 (en)	2002-05-29	2002-05-29	Compounds
GB0230053A GB0230053D0 (en)	2002-12-23	2002-12-23	Compounds
PCT/EP2003/005727 WO2003099786A2 (en)	2002-05-29	2003-05-28	Aromatic sulfones and their medical use

Publications (2)

Publication Number	Publication Date
NO20045659L true NO20045659L (no)	2004-12-27
NO330118B1 NO330118B1 (no)	2011-02-21

Family

ID=29585827

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20045659A NO330118B1 (no)	2002-05-29	2004-12-27	Nye forbindelser, farmasoytisk sammensetning, anvendelse

Country Status (25)

Country	Link
US (2)	US7504392B2 (no)
EP (1)	EP1511727B1 (no)
JP (1)	JP4268126B2 (no)
KR (1)	KR20050013196A (no)
AR (1)	AR040126A1 (no)
AT (1)	ATE354566T1 (no)
AU (1)	AU2003232846B9 (no)
BR (1)	BR0311315A (no)
CA (1)	CA2486962A1 (no)
CY (1)	CY1107053T1 (no)
DE (1)	DE60311986T2 (no)
DK (1)	DK1511727T3 (no)
ES (1)	ES2279965T3 (no)
IL (1)	IL165330A0 (no)
IS (1)	IS2482B (no)
MX (1)	MXPA04011945A (no)
MY (1)	MY133587A (no)
NO (1)	NO330118B1 (no)
NZ (1)	NZ536694A (no)
PL (1)	PL374081A1 (no)
PT (1)	PT1511727E (no)
RU (1)	RU2327690C2 (no)
SI (1)	SI1511727T1 (no)
TW (1)	TWI281914B (no)
WO (1)	WO2003099786A2 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MY133587A (en)	2002-05-29	2007-11-30	Glaxo Group Ltd	Aromatic sulfones and their medical use
MXPA04012704A (es) *	2002-06-19	2005-03-23	Schering Corp	Agonistas de los receptores canabinoides.
GB0319235D0 (en) *	2003-08-15	2003-09-17	Glaxo Group Ltd	Novel compounds
GB0327737D0 (en) *	2003-11-28	2003-12-31	Glaxo Group Ltd	Novel compounds
GB0327741D0 (en) *	2003-11-28	2003-12-31	Glaxo Group Ltd	Novel compounds
GB0327740D0 (en) *	2003-11-28	2003-12-31	Glaxo Group Ltd	Novel compounds
GB0327738D0 (en) *	2003-11-28	2003-12-31	Glaxo Group Ltd	Novel compound
GB0505437D0 (en) *	2005-03-17	2005-04-20	Merck Sharp & Dohme	Therapeutic agents
GB0505725D0 (en) *	2005-03-19	2005-04-27	Merck Sharp & Dohme	Therapeutic agents
US7671023B2 (en) *	2005-03-31	2010-03-02	Amylin Pharmaceuticals, Inc.	Amylin agonist for treating depression, anxiety disorder and schizophrenia
GB0510599D0 (en) *	2005-05-24	2005-06-29	Glaxo Group Ltd	Novel compounds
GB0603087D0 (en) *	2006-02-15	2006-03-29	Glaxo Group Ltd	Novel use
US20070293475A1 (en) *	2006-06-20	2007-12-20	Alcon Manufacturing Ltd.	Aryl and heteroaryl tetrahydrobenzazepine derivatives and their use for treating glaucoma
PT2054416E (pt) *	2006-08-04	2011-04-06	Merz Pharma Gmbh & Co Kgaa	Pirazolopirimidinas substituídas, um processo para a sua preparação e a sua utilização como medicamento
US8314090B2 (en) *	2008-11-06	2012-11-20	Ventirx Pharmaceuticals, Inc.	Methods of synthesis of benzazepine derivatives
US20180228811A1 (en) *	2014-12-12	2018-08-16	The Schepens Eye Research Institute, Inc.	Gdnf induction for the treatment of retinal disorders
US11124497B1 (en)	2020-04-17	2021-09-21	Pardes Biosciences, Inc.	Inhibitors of cysteine proteases and methods of use thereof
US11174231B1 (en)	2020-06-09	2021-11-16	Pardes Biosciences, Inc.	Inhibitors of cysteine proteases and methods of use thereof
US11351149B2 (en)	2020-09-03	2022-06-07	Pfizer Inc.	Nitrile-containing antiviral compounds

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH01503233A (ja)	1986-10-28	1989-11-02	スミス・クライン・アンド・フレンチ・ラボラトリース・リミテッド	製薬活性化合物
DE3869446D1 (de) *	1987-03-10	1992-04-30	Lion Corp	Desodorierungsmittel.
EP0285287A3 (en) *	1987-03-23	1990-08-16	Smithkline Beecham Corporation	3-benzazepine compounds for use in treating gastrointestinal motility disorders
GB8717374D0 (en)	1987-07-22	1987-08-26	Smith Kline French Lab	Pharmaceutically active compounds
US5032604A (en)	1989-12-08	1991-07-16	Merck & Co., Inc.	Class III antiarrhythmic agents
GB9127041D0 (en)	1991-12-20	1992-02-19	Fujisawa Pharmaceutical Co	New use
GB9212308D0 (en)	1992-06-10	1992-07-22	Ici Plc	Therapeutic compositions
CA2184101C (en)	1994-02-25	2005-11-22	Susumu Nakagawa	Carbapenem derivatives
US5684195A (en)	1994-07-14	1997-11-04	G. D. Searle & Co.	Method of preparing sulfmonamides from sulfones
EP0828754B1 (en)	1995-05-29	2005-02-02	Pfizer Inc.	Dipeptides which promote release of growth hormone
DE19548785A1 (de)	1995-12-27	1997-07-03	Basf Ag	Saure Polyazofarbstoffe
ATE232850T1 (de)	1996-05-11	2003-03-15	Smithkline Beecham Plc	Tetrahydroisoquinoline derivate als modulatoren von dopamine d3 rezeptoren
EP0922035B1 (en)	1996-08-14	2001-02-07	Smithkline Beecham Plc	Tetrahydroisoquinoline derivatives and their pharmaceutical use
DE19638486A1 (de)	1996-09-20	1998-03-26	Basf Ag	Hetaroylderivate
DE19638484A1 (de)	1996-09-20	1998-03-26	Basf Ag	Hetaroylderivate
NZ500590A (en)	1997-04-22	2001-11-30	Cocensys Inc	Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
GB9708805D0 (en)	1997-05-01	1997-06-25	Smithkline Beecham Plc	Compounds
EP0937723A1 (de)	1998-02-18	1999-08-25	Roche Diagnostics GmbH	Neue Sulfonamide, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
GB9804734D0 (en)	1998-03-05	1998-04-29	Pfizer Ltd	Compounds
US6344486B1 (en)	1998-04-03	2002-02-05	3-Dimensional Pharmaceuticals, Inc.	Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors
DE69914931T2 (de)	1998-10-09	2004-12-16	Janssen Pharmaceutica N.V.	4,5-dehydroisoxazole derivate und ihre pharmazeutische verwendung
TWI274750B (en)	1999-01-12	2007-03-01	Abbott Gmbh & Co Kg	Triazole compounds showing high affinity to dopamine D3 receptor and pharmaceutical composition comprising the same
RU2001126721A (ru)	1999-03-03	2004-02-20	Дзе Проктер Энд Гэмбл Компани (US)	Алкенил-и алкинилсодержащие ингибиторы металлопротезы
JP2003500386A (ja)	1999-05-24	2003-01-07	シーオーアールセラピューティクスインコーポレイテッド	Ｘａ因子阻害剤
US6531478B2 (en)	2000-02-24	2003-03-11	Cheryl P. Kordik	Amino pyrazole derivatives useful for the treatment of obesity and other disorders
ATE310728T1 (de)	2000-05-11	2005-12-15	Bristol Myers Squibb Co	Tetrahydroisochinolin-analoga als wachstumshormon-sekretagoga
US6416458B1 (en) *	2000-07-12	2002-07-09	Therion Research Inc.	Therapeutic flexible magnetic sheet and method
CA2390535C (en)	2000-09-14	2008-12-02	Edmund Gene Butts	Curling garment brush retainer
DE10053799A1 (de)	2000-10-30	2002-05-08	Bayer Ag	Verwendung von Tetrahydroisochinolinsulfonamiden
AU2303402A (en)	2000-11-14	2002-05-27	Smithkline Beecham Plc	Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
US7256201B2 (en)	2000-12-07	2007-08-14	Astrazeneca Ab	Selective estrogen receptor-β ligands
GB0111186D0 (en)	2001-05-08	2001-06-27	Smithkline Beecham Plc	Novel compounds
JP2005518414A (ja)	2001-12-21	2005-06-23	スミスクライン　ビーチャム　パブリック　リミテッド　カンパニー	ドーパミン受容体のモジュレーターとしての７−スルホニル−３−ベンゾアゼピン誘導体およびｃｎｓ障害の治療のためのその使用
ATE323680T1 (de)	2002-02-13	2006-05-15	Glaxo Group Ltd	7-arylsulfonamid-2,3,4,5-tetrahydro-1h- benzo¬däazepine mit 5-ht6 rezeptor affinität zur behandlung von zentralnervensystemerkrankungen
US20050085461A1 (en)	2002-02-13	2005-04-21	Cooper David G.	Benzenesulfonamide derivatives
PL371344A1 (en)	2002-02-13	2005-06-13	Glaxo Group Limited	Benzenesulfonamide derivatives as antipsychotic agents
GB0210762D0 (en)	2002-05-10	2002-06-19	Glaxo Group Ltd	Compounds
MY133587A (en)	2002-05-29	2007-11-30	Glaxo Group Ltd	Aromatic sulfones and their medical use
GB0212399D0 (en)	2002-05-29	2002-07-10	Glaxo Group Ltd	Compounds

2003
- 2003-05-27 MY MYPI20031957A patent/MY133587A/en unknown
- 2003-05-27 TW TW092114200A patent/TWI281914B/zh not_active IP Right Cessation
- 2003-05-27 AR ARP030101854A patent/AR040126A1/es unknown
- 2003-05-28 PT PT03755153T patent/PT1511727E/pt unknown
- 2003-05-28 MX MXPA04011945A patent/MXPA04011945A/es active IP Right Grant
- 2003-05-28 IL IL16533003A patent/IL165330A0/xx not_active IP Right Cessation
- 2003-05-28 NZ NZ536694A patent/NZ536694A/en not_active IP Right Cessation
- 2003-05-28 RU RU2004138588/04A patent/RU2327690C2/ru not_active IP Right Cessation
- 2003-05-28 JP JP2004507444A patent/JP4268126B2/ja not_active Expired - Fee Related
- 2003-05-28 US US10/515,998 patent/US7504392B2/en not_active Expired - Fee Related
- 2003-05-28 ES ES03755153T patent/ES2279965T3/es not_active Expired - Lifetime
- 2003-05-28 EP EP03755153A patent/EP1511727B1/en not_active Expired - Lifetime
- 2003-05-28 DK DK03755153T patent/DK1511727T3/da active
- 2003-05-28 PL PL03374081A patent/PL374081A1/xx not_active Application Discontinuation
- 2003-05-28 WO PCT/EP2003/005727 patent/WO2003099786A2/en not_active Ceased
- 2003-05-28 CA CA002486962A patent/CA2486962A1/en not_active Abandoned
- 2003-05-28 SI SI200330757T patent/SI1511727T1/sl unknown
- 2003-05-28 KR KR10-2004-7019172A patent/KR20050013196A/ko not_active Abandoned
- 2003-05-28 BR BR0311315-9A patent/BR0311315A/pt not_active Application Discontinuation
- 2003-05-28 AT AT03755153T patent/ATE354566T1/de active
- 2003-05-28 AU AU2003232846A patent/AU2003232846B9/en not_active Ceased
- 2003-05-28 DE DE60311986T patent/DE60311986T2/de not_active Expired - Lifetime
2004
- 2004-12-01 IS IS7577A patent/IS2482B/is unknown
- 2004-12-27 NO NO20045659A patent/NO330118B1/no not_active IP Right Cessation
2007
- 2007-04-30 CY CY20071100580T patent/CY1107053T1/el unknown
2008
- 2008-06-24 US US12/144,917 patent/US20080269197A1/en not_active Abandoned

Also Published As

Publication number	Publication date
DK1511727T3 (da)	2007-06-11
ES2279965T3 (es)	2007-09-01
AU2003232846A1 (en)	2003-12-12
WO2003099786A3 (en)	2004-09-02
PL374081A1 (en)	2005-09-19
NZ536694A (en)	2006-11-30
DE60311986D1 (de)	2007-04-05
IS7577A (is)	2004-12-01
US7504392B2 (en)	2009-03-17
CY1107053T1 (el)	2012-10-24
NO330118B1 (no)	2011-02-21
MXPA04011945A (es)	2005-03-31
BR0311315A (pt)	2005-03-01
EP1511727A2 (en)	2005-03-09
AU2003232846B2 (en)	2007-02-22
RU2327690C2 (ru)	2008-06-27
CA2486962A1 (en)	2003-12-04
TWI281914B (en)	2007-06-01
MY133587A (en)	2007-11-30
JP2005531579A (ja)	2005-10-20
US20050261279A1 (en)	2005-11-24
SI1511727T1 (sl)	2007-06-30
HK1075050A1 (en)	2005-12-02
IL165330A0 (en)	2006-01-15
JP4268126B2 (ja)	2009-05-27
ATE354566T1 (de)	2007-03-15
IS2482B (is)	2008-12-15
RU2004138588A (ru)	2005-06-27
EP1511727B1 (en)	2007-02-21
US20080269197A1 (en)	2008-10-30
DE60311986T2 (de)	2007-10-31
TW200406381A (en)	2004-05-01
AR040126A1 (es)	2005-03-16
KR20050013196A (ko)	2005-02-03
WO2003099786A2 (en)	2003-12-04
AU2003232846B9 (en)	2007-04-19
PT1511727E (pt)	2007-05-31

Publication	Publication Date	Title
ATE368042T1 (de)	2007-08-15	Cephemverbindungen
IS7471A (is)	2004-10-15	Ný efnasambönd
IS7879A (is)	2005-06-02	Ný efnasambönd
DK1605897T3 (da)	2012-08-20	Polyethelen-glycol-link-glp-1-forbindelser
FI6566U1 (fi)	2005-02-16	Läpipainopakkauslaite
IS7381A (is)	2004-08-03	Efnasambönd
NO20044046L (no)	2004-11-15	Substituerte hydroksyetylaminer
IS7414A (is)	2004-08-19	Oxó-azabísýklísk efnasambönd
NO20045659L (no)	2004-12-27	Forbindelser
IS7793A (is)	2005-04-11	Nýtt efnasamband
IS7827A (is)	2005-04-27	Ný efnasambönd
IS7794A (is)	2005-04-11	Nýtt efnasamband
ATE496887T1 (de)	2011-02-15	Substituierte 5-aminomethyl-1h-pyrrol-2-carbons ureamide
IS8089A (is)	2005-10-25	Efnasambönd
ATA1572002A (de)	2003-06-15	Managementspleisskassette
ATA4142004A (de)	2005-12-15	Trägerverbau
NO20031736D0 (no)	2003-04-15	Forbindelser
ATA19152002A (de)	2004-11-15	Hubkupplung
ATE350379T1 (de)	2007-01-15	Substituierte benzdioxepine
AT5889U3 (de)	2003-04-25	Brennholzspleisser
ATA16872002A (de)	2005-06-15	Zwischenstück
SE0203348D0 (sv)	2002-11-12	Novel compounds
ATA5582002A (de)	2003-03-15	Getränkeerhitzer
ATA15092002A (de)	2003-10-15	Beckenräumer
ATA8092002A (de)	2005-01-15	Pibf

Legal Events

Date	Code	Title	Description
2012-12-27	MM1K	Lapsed by not paying the annual fees